









Markets
/
Stocks
/
nasdaq-elv
/

Elevance Health Inc

ELV



View Detailed Chart

361.140USD

+2.070+0.58%

Market hours （ET）Quotes delayed by 15 min

80.19BMarket Cap

14.68P/E TTM



Elevance Health Inc

361.140

+2.070+0.58%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Intraday

30m

Today

+0.58%

5 Days

+9.19%

1 Month

+10.84%

6 Months

-6.09%

Year to Date

-2.10%

1 Year

-5.31%

View Detailed Chart

TradingKey Stock Score of Elevance Health Inc

Currency: USD Updated: 2025-12-12

Key Insights

Elevance Health Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 31/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 384.35.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and strong technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Elevance Health Inc's Score

Industry at a Glance

Industry Ranking

31 / 78

Overall Ranking

150 / 4592

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Analyst Rating

Based on 24 analysts

Buy

Current Rating

384.355

Target Price

+16.26%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Elevance Health Inc Highlights

StrengthsRisks

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 25.38%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 25.38%.

Undervalued

The company’s latest PE is 14.60, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 205.92M shares, increasing 0.01% quarter-over-quarter.

Held by Frank Sands

Star Investor Frank Sands holds 93.12K shares of this stock.

Elevance Health Inc News

U.S. STOCKS ON THE MOVE-TAL Education, Elevance, General Electric

Eikon search string for individual stock moves: The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8U.S. stock index futures were subdued on Thursday, as investors paused after Wall Street's strong performance in the previous session and ...

ReutersThu, Jan 23